Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Oseltamivir Dosing Strategies for Influenza Prophylaxis
NCT00334529Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oseltamivir in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2006; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00334529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334529.